Rabies is a fatal neurological disease, usually spread to humans through the bite of a rabid animal, and it is a persistent global problem. In 2018, the global Human Rabies Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Human Rabies Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Human Rabies Treatment development in United States, Europe and China.
The key players covered in this study Biological E Ltd. Cadila Healthcare Grifols S.A. Kamada Ltd. Kedrion S.p.A. Novartis International AG Sanofi Pasteur SA Serum institute of India
Market segment by Type, the product can be split into Cell Culture Vaccines Rabies Immunoglobulin Nerve Tissue Vaccines
Market segment by Application, split into Pre-Exposure Immunization Post-Exposure Prophylaxis
Market segment by Regions/Countries, this report covers United States Europe China Japan Southeast Asia India Central & South America
The study objectives of this report are: To analyze global Human Rabies Treatment status, future forecast, growth opportunity, key market and key players. To present the Human Rabies Treatment development in United States, Europe and China. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Human Rabies Treatment are as follows: History Year: 2014-2018 Base Year: 2018 Estimated Year: 2019 Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Human Rabies Treatment Market Size Growth Rate by Type (2014-2025) 1.4.2 Cell Culture Vaccines 1.4.3 Rabies Immunoglobulin 1.4.4 Nerve Tissue Vaccines 1.5 Market by Application 1.5.1 Global Human Rabies Treatment Market Share by Application (2014-2025) 1.5.2 Pre-Exposure Immunization 1.5.3 Post-Exposure Prophylaxis 1.6 Study Objectives 1.7 Years Considered
2 Global Growth Trends 2.1 Human Rabies Treatment Market Size 2.2 Human Rabies Treatment Growth Trends by Regions 2.2.1 Human Rabies Treatment Market Size by Regions (2014-2025) 2.2.2 Human Rabies Treatment Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities
3 Market Share by Key Players 3.1 Human Rabies Treatment Market Size by Manufacturers 3.1.1 Global Human Rabies Treatment Revenue by Manufacturers (2014-2019) 3.1.2 Global Human Rabies Treatment Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Human Rabies Treatment Market Concentration Ratio (CR5 and HHI) 3.2 Human Rabies Treatment Key Players Head office and Area Served 3.3 Key Players Human Rabies Treatment Product/Solution/Service 3.4 Date of Enter into Human Rabies Treatment Market 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application 4.1 Global Human Rabies Treatment Market Size by Type (2014-2019) 4.2 Global Human Rabies Treatment Market Size by Application (2014-2019)
5 United States 5.1 United States Human Rabies Treatment Market Size (2014-2019) 5.2 Human Rabies Treatment Key Players in United States 5.3 United States Human Rabies Treatment Market Size by Type 5.4 United States Human Rabies Treatment Market Size by Application
6 Europe 6.1 Europe Human Rabies Treatment Market Size (2014-2019) 6.2 Human Rabies Treatment Key Players in Europe 6.3 Europe Human Rabies Treatment Market Size by Type 6.4 Europe Human Rabies Treatment Market Size by Application
7 China 7.1 China Human Rabies Treatment Market Size (2014-2019) 7.2 Human Rabies Treatment Key Players in China 7.3 China Human Rabies Treatment Market Size by Type 7.4 China Human Rabies Treatment Market Size by Application
8 Japan 8.1 Japan Human Rabies Treatment Market Size (2014-2019) 8.2 Human Rabies Treatment Key Players in Japan 8.3 Japan Human Rabies Treatment Market Size by Type 8.4 Japan Human Rabies Treatment Market Size by Application
9 Southeast Asia 9.1 Southeast Asia Human Rabies Treatment Market Size (2014-2019) 9.2 Human Rabies Treatment Key Players in Southeast Asia 9.3 Southeast Asia Human Rabies Treatment Market Size by Type 9.4 Southeast Asia Human Rabies Treatment Market Size by Application
10 India 10.1 India Human Rabies Treatment Market Size (2014-2019) 10.2 Human Rabies Treatment Key Players in India 10.3 India Human Rabies Treatment Market Size by Type 10.4 India Human Rabies Treatment Market Size by Application
11 Central & South America 11.1 Central & South America Human Rabies Treatment Market Size (2014-2019) 11.2 Human Rabies Treatment Key Players in Central & South America 11.3 Central & South America Human Rabies Treatment Market Size by Type 11.4 Central & South America Human Rabies Treatment Market Size by Application
12 International Players Profiles 12.1 Biological E Ltd. 12.1.1 Biological E Ltd. Company Details 12.1.2 Company Description and Business Overview 12.1.3 Human Rabies Treatment Introduction 12.1.4 Biological E Ltd. Revenue in Human Rabies Treatment Business (2014-2019) 12.1.5 Biological E Ltd. Recent Development 12.2 Cadila Healthcare 12.2.1 Cadila Healthcare Company Details 12.2.2 Company Description and Business Overview 12.2.3 Human Rabies Treatment Introduction 12.2.4 Cadila Healthcare Revenue in Human Rabies Treatment Business (2014-2019) 12.2.5 Cadila Healthcare Recent Development 12.3 Grifols S.A. 12.3.1 Grifols S.A. Company Details 12.3.2 Company Description and Business Overview 12.3.3 Human Rabies Treatment Introduction 12.3.4 Grifols S.A. Revenue in Human Rabies Treatment Business (2014-2019) 12.3.5 Grifols S.A. Recent Development 12.4 Kamada Ltd. 12.4.1 Kamada Ltd. Company Details 12.4.2 Company Description and Business Overview 12.4.3 Human Rabies Treatment Introduction 12.4.4 Kamada Ltd. Revenue in Human Rabies Treatment Business (2014-2019) 12.4.5 Kamada Ltd. Recent Development 12.5 Kedrion S.p.A. 12.5.1 Kedrion S.p.A. Company Details 12.5.2 Company Description and Business Overview 12.5.3 Human Rabies Treatment Introduction 12.5.4 Kedrion S.p.A. Revenue in Human Rabies Treatment Business (2014-2019) 12.5.5 Kedrion S.p.A. Recent Development 12.6 Novartis International AG 12.6.1 Novartis International AG Company Details 12.6.2 Company Description and Business Overview 12.6.3 Human Rabies Treatment Introduction 12.6.4 Novartis International AG Revenue in Human Rabies Treatment Business (2014-2019) 12.6.5 Novartis International AG Recent Development 12.7 Sanofi Pasteur SA 12.7.1 Sanofi Pasteur SA Company Details 12.7.2 Company Description and Business Overview 12.7.3 Human Rabies Treatment Introduction 12.7.4 Sanofi Pasteur SA Revenue in Human Rabies Treatment Business (2014-2019) 12.7.5 Sanofi Pasteur SA Recent Development 12.8 Serum institute of India 12.8.1 Serum institute of India Company Details 12.8.2 Company Description and Business Overview 12.8.3 Human Rabies Treatment Introduction 12.8.4 Serum institute of India Revenue in Human Rabies Treatment Business (2014-2019) 12.8.5 Serum institute of India Recent Development
13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 15.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details